Cryopreserved Allograft Use in Vascular Surgery

Jani Lee1, Mabel C Chan1, Crystal James1

  • 1Mount Sinai Morningside and West Hospitals, New York, NY.

Insights

Cryopreserved arterial and venous allografts offer a superior alternative to prosthetic grafts in vascular surgery due to their resistance to infection. These allografts are increasingly the preferred choice for bypass procedures, including lower-extremity, aortic, and dialysis access applications.

Area of Science:

  • Vascular Surgery
  • Biomaterials Science
  • Transplantation Immunology

Background:

  • Bypass procedures are essential for treating arterial and venous diseases.
  • Autogenous conduits are ideal but often unavailable.
  • Prosthetic grafts are common but prone to infection.

Purpose of the Study:

  • To discuss the clinical applications of cryopreserved arterial and venous allografts in vascular surgery.
  • To highlight the advantages of allografts over prosthetic grafts, particularly regarding infection resistance.
  • To focus on specific applications: lower-extremity bypass, aortic disease, and dialysis access.

Main Methods:

  • Review of clinical applications and outcomes of cryopreserved allografts.
  • Comparison of infection rates between allografts and prosthetic grafts.
  • Analysis of suitability for various vascular reconstructions.

Main Results:

  • Cryopreserved allografts demonstrate relative resistance to infection compared to prosthetic grafts.
  • Allografts are effective conduits for lower-extremity peripheral bypass.
  • Successful use of allografts in managing aortic disease and creating dialysis access.

Conclusions:

  • Cryopreserved arterial and venous allografts are a valuable and infection-resistant option in vascular surgery.
  • Their application in lower-extremity bypass, aortic disease, and dialysis access is clinically significant.
  • Allografts represent a preferred conduit choice when autogenous options are not feasible and infection risk is a concern.

Related Concept Videos